ArticleCanadian respiratory journal2024

Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Expression via MET/STAT3/Akt Pathway.

Lile Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.